Preventing T2DM After GDM With Immediate Postpartum Screening
Recruiting now · Not applicable
Conditions studied: Gestational Diabetes, Type 2 Diabetes
In brief
The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.
Key facts
- Study ID
- NCT06457139
- Run by
- University of Massachusetts, Worcester
- People needed
- 116
- Starts
- 2025-06-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-06-24
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria
- receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial
- able and willing to provide informed consent
- ability to complete immediate in hospital postpartum glucose testing
- have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL
You may not qualify if…
- known diagnosis of pre-existing pre-gestational diabetes in pregnancy
- inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum
- systemic steroid use
Where it is running
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.